Quant Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.08%)Nav, as on 21-11-2025

  • Previous Nav

  • Net Change on 21-11-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 2.88 21.93 17.63 1.80 8,346.49
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 7.64 27.80 20.28 1.87 6,437.36
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 3.92 24.30 19.14 1.93 4,082.13
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -2.72 21.41 17.27 1.91 3,143.91
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 3.80 20.93 17.23 1.93 2,821.22

Fund Holdings as on 31-October-2025

  • TREPS 03-Nov-2025 DEPO 10

  • Cipla Limited 25/11/2025

  • Sequent Scientific Limited

  • Zydus Wellness Ltd

  • Aster DM Healthcare Limited

  • Lupin Limited 25/11/2025

  • SMS Pharmaceuticals Limited

  • Pfizer Ltd

  • Aurobindo Pharma Limited

  • ANTHEM BIOSCIENCES LIMITED

  • Adani Enterprises Limited

  • Alivus Life Sciences

  • Divi's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Aurobindo Pharma Limited 25/11/2025

  • Concord Biotech Limited

  • Lupin Limited

  • Godrej Properties Limited

  • 91 Days Treasury Bill 18-Dec-2025

  • Gland Pharma Limited

  • 91 Days Treasury Bill 20-Nov-2025

  • 91 Days Treasury Bill 28-Nov-2025

  • 91 Days Treasury Bill 04-Dec-2025

  • 91 Days Treasury Bill 02-Jan-2026

  • 91 Days Treasury Bill 15-Jan-2026

  • 91 Days Treasury Bill 23-Jan-2026

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Consumer Food

  • Hospital & Healthcare Services

  • Trading

  • Construction - Real Estate

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • SOV

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹383.96 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Quant Healthcare Fund ended down ₹-0.17(-1.08%)yesterday to ₹15.2529.

Among its top 3 holdings the fund has exposure to TREPS 03-Nov-2025 DEPO 10, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000